Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine

Brian S. Barnetta Department of Psychiatry and Psychology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA;b Cleveland Clinic, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USACorrespondence[email protected]

https://orcid.org/0000-0002-8963-5701

Curtis J. Koonsc Department of Anesthesia, Pikeville Medical Center, Pikeville, KY, USA

Vincent Van den Eynded PsychoTropical Research, Bucasia, QLD, Australia;e Department of Psychiatry, RadboudUMC, Nijmegen, The Netherlands

Peter Kenneth Gillmand PsychoTropical Research, Bucasia, QLD, Australia

J. Alexander Bodkinf Department of Psychiatry, McLean Hospital, Belmont, MA, USA;g Department of Psychiatry, Harvard Medical School, Boston, MA, USA

Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date